Tangier Disease: Epidemiology, Pathophysiology, and Management

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.12, Iss.5, 2012-10, pp. : 303-311

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lafora Disease: Epidemiology, Pathophysiology and Management

By Monaghan Thomas S. Delanty Norman

CNS Drugs, Vol. 24, Iss. 7, 2010-07 ,pp. : 549-561

Adis International

Access to resources Recommend Favorite

Poststroke Epilepsy: Epidemiology, Pathophysiology and Management

By José M. Ferro

Drugs & Aging, Vol. 21, Iss. 10, 2004-01 ,pp. : 639-653

Adis International

Access to resources Recommend Favorite

Gastrointestinal Motility Problems in Patients with Parkinsons Disease: Epidemiology, Pathophysiology and Guidelines for Management

By Pfeiffer R.F.

CNS Drugs, Vol. 11, Iss. 6, 1999-06 ,pp. : 435-448

Adis International

Access to resources Recommend Favorite

Antipsychotic-Induced Rabbit Syndrome: Epidemiology, Management and Pathophysiology

By Schwartz M.

CNS Drugs, Vol. 18, Iss. 4, 2004-01 ,pp. : 213-220

Adis International

Access to resources Recommend Favorite

Guillain-Barré Syndrome: Epidemiology, Pathophysiology and Management

By Kuwabara S.

Drugs, Vol. 64, Iss. 6, 2004-01 ,pp. : 597-610

Adis International

Access to resources Recommend Favorite